Germany’s Inovedis bags €3.78M to commercialise SINEFIX surgical system to reduce surgery time, costs

Germany-based Inovedis, a medical startup  that gives modern options to optimise affected person care and minimise the complexity of surgical intervention, introduced that it closed a Collection A spherical of funding at €3.78M. 

The funding spherical was participated by Inovedis’ complete preliminary seed spherical buyers, together with Excessive-Tech Gründerfonds, MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg, Volksbank Albstadt ChancenKapital, Begin-UP BW Innovation Fonds, and angel buyers, and an preliminary funding by Renolit SE, the present producer of the SINEFIX implant.

Inovedis says it would use the funding to help the industrial launch of the SINEFIX implant system in the USA. The beginning-up can even use the fund to sponsor a scientific research in Germany to create information essential to help CE marking and gross sales growth into Europe.

About Inovedis

Trauma and orthopaedic surgeon Dr Stefan Welte and entrepreneur Lukas Floess based Inovedis in 2019. Primarily based in Albstadt, Germany, Inovedis goals to offer medical options to create optimised affected person care and scale back time and price within the healthcare sector.